Health Care · S&P 500
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a US biopharma company best known for its cystic fibrosis treatments. S&P 500 constituent. Sector: Health Care (Biotechnology). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
VRTX Updated Jul 11, 2026 2 AI consumers
Annual return · 2026-07-10'21-7.1%'22+31.5%'23+40.9%'24-1%'25+12.6%YTD+7.1%
Money in ▸·
Vertex Pharmaceuticalsapprox. $11.0B
▸ Money out·
Financials & Segments
- Total revenue · approx. $11.0B (FY2024)
- Segments · Cystic Fibrosis Products
Revenue from
No refined links yet.
Pays to
No refined links yet.